Chagas' disease is one of the world most neglected diseases. It is estimated that 16 million infected people are living in Latin-American and due to immigration, more than 100,000 are living in USA.. Chagas cardiomyopathy (ChC) is an important cause of end-stage heart failure. Goal: to evaluate the incidence of reactivation (Ra) and cardiac allograft vasculopathy (CAV) in patients (pts) with heart transplant (HTx) due to Chagas' cardiomyopathy (ChC) and compare the outcome of this pts to others aetiologies.
